PubRank

G Siest

Author PubWeight™ 200.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ 2001 2.74
2 Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998 2.41
3 A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999 2.13
4 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995 1.55
5 Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet 2000 1.53
6 Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J 2005 1.53
7 Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991 1.42
8 Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 1975 1.39
9 An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet 1990 1.36
10 The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol 1991 1.35
11 Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998 1.29
12 Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001 1.26
13 gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998 1.26
14 Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 2000 1.24
15 Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem 1995 1.24
16 Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics 1992 1.20
17 Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem 1983 1.16
18 UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol 1983 1.14
19 Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 1998 1.11
20 Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000 1.06
21 Need for revisiting the concept of reference values. Clin Chem Lab Med 2000 1.04
22 Subcellular distribution of cytochrome P-450 in the brain. Brain Res 1986 1.04
23 Dietary intakes, eating style and overweight in the Stanislas Family Study. Int J Obes Relat Metab Disord 2000 1.03
24 Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 1993 1.03
25 Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem 1988 1.03
26 Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med 1999 1.03
27 A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998 1.01
28 Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Brain Res Rev 1991 1.01
29 Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 1992 1.00
30 Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 1993 0.98
31 Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 1994 0.98
32 High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med 2000 0.98
33 Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet 1998 0.98
34 Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994 0.97
35 Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet 2001 0.97
36 Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 2001 0.97
37 Expression of multiple gamma-glutamyltransferase genes in man. Biochem J 1994 0.96
38 An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet 1989 0.95
39 Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology 1990 0.95
40 Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol 1998 0.94
41 Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int J Obes (Lond) 2008 0.94
42 Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem 1998 0.93
43 In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther 1992 0.92
44 Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry 2001 0.92
45 Relations between reported alcohol consumption and certain biological variables in an "unselected" population. Clin Chem 1979 0.92
46 Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study. Biochim Biophys Acta 2000 0.91
47 Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol 1996 0.91
48 ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. Clin Chim Acta 1986 0.90
49 Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 1998 0.90
50 Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica 1986 0.89
51 An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann Biol Clin (Paris) 1986 0.89
52 The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Lett 1994 0.89
53 Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Biochem Pharmacol 1992 0.89
54 Electrophoretic mobility, rosette formation and surface immunoglobulins of gradient fractionated human blood lymphocytes. Biomedicine 1974 0.88
55 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord 2000 0.88
56 Genetic Polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann Hum Genet 2008 0.88
57 Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res 1996 0.88
58 Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem J 1999 0.88
59 Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones. Biochim Biophys Acta 1992 0.88
60 Soluble transferrin receptor (sTfR): biological variations and reference limits. Clin Chem Lab Med 2001 0.87
61 Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. Mol Pharmacol 1991 0.87
62 Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. J Lipid Res 2001 0.87
63 Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clin Chim Acta 1981 0.86
64 Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population. Clin Genet 1996 0.86
65 Total cholinesterase in plasma: biological variations and reference limits. Clin Chem 1985 0.86
66 Weights at birth and in early infancy, systolic pressure, and left ventricular structure in subjects aged 8 to 24 years. Hypertension 1996 0.86
67 LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest 2001 0.86
68 The glucuronosyltransferases: what progress can pharmacologists expect from molecular biology and cellular enzymology? Biochem Pharmacol 1987 0.85
69 Evidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzyme. Free Radic Biol Med 2000 0.85
70 Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 2000 0.85
71 Albendazole sulfonation by rat liver cytochrome P-450c. J Pharmacol Exp Ther 1988 0.85
72 Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J Neurol Sci 1997 0.85
73 A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol 1994 0.85
74 A novel UDP-Glc-specific glucosyltransferase catalyzing the biosynthesis of 6-O-glucosides of bile acids in human liver microsomes. J Biol Chem 1993 0.85
75 Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys 1990 0.84
76 Induction of recombinant human gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO Chinese hamster cells. Biochem Biophys Res Commun 1993 0.84
77 Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort. Pharmacogenomics J 2005 0.84
78 Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles. Genes Immun 2007 0.84
79 Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease? Clin Chem 1996 0.84
80 Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide. Mol Pharmacol 1995 0.83
81 [Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies]. Ann Biol Clin (Paris) 2004 0.83
82 Inducibility of rat brain drug-metabolizing enzymes. Eur J Drug Metab Pharmacokinet 1988 0.83
83 High sensitivity C-reactive protein (CRP) reference intervals in the elderly. Clin Chem Lab Med 2001 0.83
84 A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels. Life Sci 1988 0.83
85 Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem 1977 0.83
86 Kinetic properties of gamma-glutamyltransferase from human liver. Clin Chem 1980 0.82
87 Phenobarbital induction of cytochrome P-450 and UDP-glucuronosyltransferase in rabbit liver plasma membranes. Enzyme 1982 0.82
88 Electrophoretic mobility of gamma-glutamyltransferase in rat liver subcellular fractions. Evidence for structure difference from the kidney enzyme. Biochem J 1989 0.82
89 Expression and regulation of drug metabolizing enzymes in an immortalized rat hepatocyte cell line. Biochem Pharmacol 1991 0.82
90 Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes. Biochem Pharmacol 1987 0.82
91 [Viral theory of atherosclerosis. Role of cytomegalovirus]. Ann Biol Clin (Paris) 1993 0.82
92 Some kinetic properties of gamma-glutamyltransferase from rabbit liver. Biochim Biophys Acta 1981 0.82
93 [Study of the determination of urea and citrulline in protein-containing media. Manual and automatic diacetylmonoxime method]. Clin Chim Acta 1968 0.82
94 [Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations]. Ann Biol Clin (Paris) 2002 0.81
95 Plasma lecithin:cholesterol acyltransferase -- reference values and effects of xenobiotics. Clin Chim Acta 1983 0.81
96 The 5' untranslated region of the human gamma-glutamyl transferase mRNA contains a tissue-specific active translational enhancer. FEBS Lett 1993 0.81
97 Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metab Dispos 1991 0.81
98 Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis 1998 0.81
99 [Interference of oral contraceptives and antiepileptics on plasma parameters in man. Special enzyme study]. Therapie 1975 0.81
100 Interaction between human amphipathic apolipoproteins and amyloid beta-peptide: surface plasmon resonance studies. FEBS Lett 1996 0.81
101 Assessment of the Mulder and Van Doorn kinetic procedure and rapid centrifugal analysis of UDP-glucuronosyltransferase activities. J Biochem Biophys Methods 1984 0.81
102 Expression of arylhydrocarbon hydroxylase, epoxide hydrolases, glutathione S-transferase and UDP-glucuronosyltransferases in H5-6 hepatoma cells. Gen Pharmacol 1991 0.81
103 Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases. Clin Chim Acta 1994 0.81
104 Localization of gamma-glutamyltransferase in subcellular fractions of rat and rabbit liver: effect of phenobarbital. Biochem Pharmacol 1979 0.81
105 Uses of gamma-glutamyltransferase in experimental toxicology. Adv Vet Sci Comp Med 1987 0.81
106 Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix. FEBS Lett 1999 0.80
107 Protein-lipid interactions in reconstituted high density lipoproteins: apolipoprotein and cholesterol influence. Chem Phys Lipids 2001 0.80
108 Simultaneous measurement of reactive oxygen species and reduced glutathione using capillary electrophoresis and laser-induced fluorescence detection in cultured cell lines. Electrophoresis 1999 0.80
109 High-level expression of enzymatically active mature human gamma-glutamyltransferase in transgenic V79 Chinese hamster cells. Proc Natl Acad Sci U S A 1991 0.80
110 Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase activities. Conjugations of phenolic and monoterpenoid aglycones in control and induced rats and guinea pigs. Biochem Pharmacol 1985 0.80
111 Signal peptide-length variation in human apolipoprotein B gene. Molecular characteristics and association with plasma glucose levels. Diabetes 1991 0.80
112 Heterogeneity of hepatic microsomal UDP-glucuronosyltransferases activities: use and comparison of differential inductions in some mammalian species. Comp Biochem Physiol B 1987 0.80
113 Dextromethorphan O-demethylase activity in rat brain microsomes. Neurosci Lett 1995 0.80
114 Modulation of UDPglucuronosyltransferase activity in rats by dietary lipids. J Nutr 1986 0.80
115 Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up. J Chromatogr 1987 0.80
116 Reference limits of apolipoprotein A-I and apolipoprotein B using an IFCC standardized immunonephelometric method. Eur J Clin Chem Clin Biochem 1995 0.80
117 Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 1995 0.80
118 Age-related variations of enzymatic defenses against free radicals and peroxides. EXS 1992 0.80
119 Blood activities of antioxidant enzymes in alcoholics before and after withdrawal. J Stud Alcohol 1993 0.80
120 Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: comparison between human and mammalian species activities. Chem Biol Interact 1984 0.80
121 Studies of UDP-glucuronosyltransferase activity toward eugenol, using a gas chromatographic method of measurement. Anal Biochem 1983 0.80
122 Family resemblance in breakfast energy intake: the Stanislas Family Study. Eur J Clin Nutr 2002 0.80
123 Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest 1990 0.80
124 Liquid chromatographic assay for the measurement of glucuronidation of arylcarboxylic acids using uridine diphospho-[U-14C] glucuronic acid. J Chromatogr 1986 0.79
125 Factors affecting the concentration of triacylglycerols (triglycerides in plasma: reference values for adults. Clin Chem 1979 0.79
126 Associations of apolipoprotein E concentration and polymorphism with lipids and apolipoprotein levels in Chinese from Beijing and Shanghai. Clin Chem Lab Med 2000 0.79
127 Determination of the human liver UDP-glucuronosyltransferase 2B4 domains involved in the binding of UDP-glucuronic acid using photoaffinity labeling of fusion proteins. Biochem Biophys Res Commun 1993 0.79
128 [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism]. Pathol Biol (Paris) 1987 0.79
129 Highly sensitive immuno-assays for the determination of cotinine in serum and saliva. Comparison between RIA and an avidin-biotin ELISA. Eur J Clin Chem Clin Biochem 1991 0.79
130 Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic process. Arch Biochem Biophys 1994 0.79
131 Frequency and effects of the apolipoprotein A-IV polymorphism. Clin Genet 1990 0.79
132 Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. Biochim Biophys Acta 1999 0.79
133 Differential effects of human recombinant interleukin-1 beta on cytochrome P-450-dependent activities in cultured fetal rat hepatocytes. Drug Metab Dispos 1992 0.79
134 Reference materials for clinical enzymology: the work of the Community Bureau of Reference of the European Community. Clin Chem 1986 0.79
135 Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res 1997 0.79
136 Drug interference in clinical chemistry: studies on ascorbic acid. J Clin Chem Clin Biochem 1978 0.79
137 Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases. Curr Pharm Des 2009 0.78
138 Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci Lett 1996 0.78
139 Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Biochim Biophys Acta 2000 0.78
140 Distribution of plasma amino acids in humans during submaximal prolonged exercise. Eur J Appl Physiol Occup Physiol 1974 0.78
141 Automated quantification of bone and liver alkaline phosphatase isoenzymes of human serum. Clin Chim Acta 1980 0.78
142 Biological effects of eleven combined oral contraceptives on serum triglycerides, gamma-glutamyltransferase, alkaline phosphatase, bilirubin and other biochemical variables. Clin Chem Lab Med 1998 0.78
143 Simultaneous determination of uric acid and creatinine in plasma by reversed-phase liquid chromatography. Clin Chem 1985 0.78
144 Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines. Cell Biol Toxicol 1989 0.78
145 Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 1993 0.78
146 Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease. Am J Med Genet 1994 0.78
147 gamma-Glutamyltransferase of rabbit liver: Kinetic study of phenobarbital induction and in vitro solubilization by bile salts. Toxicol Appl Pharmacol 1980 0.78
148 Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels. J Lipid Res 1999 0.78
149 Purification and characterization of a catalytically active human liver UDP-glucuronosyltransferase expressed as a fusion protein in E. coli. Biochem Biophys Res Commun 1993 0.78
150 Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2. Cell Biochem Funct 2001 0.78
151 Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic? Eur J Clin Pharmacol 1991 0.78
152 Measurement of thiols in human plasma using liquid chromatography with precolumn derivatization and fluorescence detection. J Chromatogr Sci 1999 0.78
153 Brain mitochondrial cytochrome P-450scc: spectral and catalytic properties. Arch Biochem Biophys 1987 0.78
154 Associations between serum gamma-glutamyltransferase and apolipoproteins: relationships with hepatobiliary diseases. Clin Chem 1984 0.78
155 Production and certification of an enzyme reference material for gamma-glutamyltransferase (CRM 319). Part 1: Preparation and characterization. Clin Chem 1987 0.78
156 The effect of dietary sulfur-containing amino acids on the activity of drug-metabolizing enzymes in rat-liver microsomes. J Nutr 1979 0.78
157 Variations in total phospholipids and high-density lipoprotein phospholipids in plasma from a general population: reference intervals and influence of xenobiotics. Clin Chem 1985 0.78
158 Quantitative determination of granulocytic amino acids in healthy men and women. Clin Chim Acta 1976 0.78
159 Drug metabolizing enzymes in the rat pituitary gland. Prog Brain Res 1992 0.78
160 Reference limits of plasma fibrinogen. Eur J Clin Chem Clin Biochem 1992 0.78
161 Differential time-course of induction of rat liver gamma-glutamyltransferase and drug-metabolizing enzymes in the endoplasmic reticulum, Golgi and plasma membranes after a single phenobarbital injection. Evaluation of protein variations by two-dimensional electrophoresis. Cell Biochem Funct 1987 0.78
162 Differential regulation of two microsomal epoxide hydrolases in hyperplastic nodules from rat liver. Carcinogenesis 1984 0.78
163 Measurement of plasma gamma-glutamyltransferase in clinical chemistry: kinetic basis and standardisation propositions. Clin Chim Acta 1981 0.77
164 Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxide hydrolases and UDP-glucuronosyltransferases in rat liver. Biochem Pharmacol 1988 0.77
165 Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine. Toxicol Lett 2003 0.77
166 Kinetic properties of UDP-glucuronosyltransferase(S) in different membranes of rat liver cells. Xenobiotica 1984 0.77
167 Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors. Nutr Metab Cardiovasc Dis 2009 0.77
168 Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in the Chinese from Shanghai. Clin Chem Lab Med 1998 0.77
169 Total, tartrate-resistant, and tartrate-inhibited acid phosphatases in serum: biological variations and reference limits. Clin Chem 1988 0.77
170 Expression and role of the human liver UDP-glucuronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in Escherichia coli. Arch Biochem Biophys 1994 0.77
171 Two-dimensional electrophoresis of plasma proteins and high density lipoproteins during inflammation. Electrophoresis 1989 0.77
172 [Reference values of plasma and lipoprotein cholesterol and triacylglycerols in healthy children]. Arch Fr Pediatr 1984 0.77
173 In vitro irreversible binding of ketoprofen glucuronide to plasma proteins. Drug Metab Dispos 1993 0.77
174 Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal. Clin Chim Acta 1996 0.77
175 Control of apolipoprotein E secretion by 25-hydroxycholesterol and proinflammatory cytokines in the human astrocytoma cell line CCF-STTG1. Cell Biol Toxicol 2001 0.77
176 Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett 1994 0.77
177 Effect of phenobarbital on the distribution of gamma-glutamyltransferase between hepatocytes and nonparenchymal cells in the rat. Cell Mol Biol Incl Cyto Enzymol 1980 0.77
178 Stability of blood homocysteine and other thiols: EDTA or acidic citrate? Clin Chem 1999 0.77
179 Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions. Neurosci Lett 1987 0.77
180 Molecular and functional characterization of recombinant human gamma-glutamyltransferase. Coupling of its activity to glutathione levels in V79 cells. Eur J Biochem 1994 0.77
181 Substrate specificity and enantioselectivity of arylcarboxylic acid glucuronidation. Drug Metab Dispos 1988 0.77
182 Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci Lett 1998 0.77
183 Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results. J Pharm Pharmacol 1988 0.77
184 Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels. Biochem Pharmacol 1990 0.77
185 Familial studies on the genetics of cardiovascular diseases: the Stanislas cohort. Clin Chem Lab Med 2000 0.77
186 Differential effects of human recombinant interleukin-1 beta and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats. Biochem Pharmacol 1993 0.77
187 Differential toxicity of aflatoxin B1 in male and female rats: relationship with hepatic drug-metabolizing enzymes. Biochem Pharmacol 1982 0.77
188 [Prevalence of viral hepatitis B markers in a sample population seen at a center of preventive medicine]. Pathol Biol (Paris) 1986 0.77
189 [Changes of plasma and tissue gamma-glutamyltransferase under the influence of drugs]. Therapie 1989 0.77
190 Bivariate familial correlation analysis of quantitative traits by use of estimating equations: application to a familial analysis of the insulin resistance syndrome. Genet Epidemiol 1999 0.77
191 Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells. Neurosci Lett 2003 0.77
192 Novel inhibitors and substrates of bilirubin: UDP-glucuronosyltransferase. Arylalkylcarboxylic acids. Eur J Biochem 1989 0.76
193 6 beta-hydroxycortisol in serum and urine as determined by enzyme immunoassay on microtitre plates. Clin Chem 1986 0.76
194 Clinical significance of a new isoform of serum alanine aminopeptidase; relationship with liver disease and alcohol consumption. Clin Chim Acta 1989 0.76
195 Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism. Genet Epidemiol 1994 0.76
196 Comparative induction of drug-metabolizing enzymes by hypolipidaemic compounds. Gen Pharmacol 1989 0.76
197 Hepatic membrance gamma-glutamyltransferase solubilization facilitated after administration of phenobarbital. Pharmacol Res Commun 1979 0.76
198 Effects of aflatoxin B1 on the activity of drug-metabolizing enzymes in rat liver. Toxicol Appl Pharmacol 1981 0.76
199 Rapid liquid chromatographic assay of glutathione in cultured cells. Biomed Chromatogr 1993 0.76
200 Malondialdehyde adducts to, and fragmentation of, apolipoprotein B from human plasma. Clin Chim Acta 1993 0.76
201 Gamma-glutamyltransferase from human hepatoma cell lines: purification and cell culture of HepG2 on microcarriers. Clin Chim Acta 1990 0.76
202 Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate. Biochim Biophys Acta 1985 0.76
203 Expression of rat renal gamma-glutamyltransferase cDNA in Escherichia coli. Biochem Biophys Res Commun 1989 0.76
204 Apolipoprotein E level in cerebrospinal fluid increases with aging. J Am Geriatr Soc 1997 0.76
205 Variations in sialic acid content of gamma-glutamyltransferase: a consequence for immunochemical determinations? Clin Chim Acta 1985 0.76
206 Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort. J Hypertens 2000 0.76
207 Enzyme induction by drugs and toxins. Clin Chim Acta 1992 0.76
208 Inhibition of bilirubin UDPglucuronosyltransferase activity by triphenylacetic acid and related compounds. Biochim Biophys Acta 1986 0.76
209 Induction of liver microsomal cytochrome P-450 isozymes by 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide. Xenobiotica 1989 0.76
210 An intronic promoter controls the expression of truncated human gamma-glutamyltransferase mRNAs. FEBS Lett 1998 0.76
211 In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-beta-D-glucuronide. J Neurochem 1991 0.76
212 Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1*6. Biochem Pharmacol 1995 0.76
213 Influence of the isolation method on the stability of differentiated phenotype in cultured rat hepatocytes. J Pharmacol Methods 1991 0.76
214 Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes. Biochem Pharmacol 1981 0.76
215 Different constructs for the expression of mammalian gamma-glutamyltransferase cDNAs in Escherichia coli and in Saccharomyces cerevisiae. Clin Chem 1991 0.76
216 Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism. Atherosclerosis 2001 0.76
217 Functional heterogeneity of UDP-glucuronosyltransferases in different membranes of rat liver. Biochem Pharmacol 1983 0.76
218 Effects of pro-inflammatory cytokines on apolipoprotein E secretion by a human astrocytoma cell line (CCF-STTG1). Cell Biochem Funct 2000 0.76
219 Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population. Clin Chem Lab Med 2001 0.76
220 [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)]. Therapie 1989 0.76
221 Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. Biochem Pharmacol 1989 0.76
222 Lack of a genetic polymorphism in the glucuronidation of fenofibric acid. Pharmacogenetics 1995 0.76
223 Heterogeneity of hepatic UDP-glucuronosyltransferase activities: investigations of isoenzymes involved in p-nitrophenol glucuronidation. Comp Biochem Physiol C 1993 0.76
224 Influence of three inducers on rabbit gamma-glutamyltransferase. Pharmacol Res Commun 1980 0.76
225 Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis. Clin Chem 1987 0.75
226 Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study". Hum Genet 1993 0.75
227 Cloning and expression of a novel type (III) of human gamma-glutamyltransferase truncated mRNA. FEBS Lett 1996 0.75
228 Further validation of the Mulder and van Doorn kinetic procedure for the measurement of microsomal UDP-glucuronosyltransferase activities. Biochem J 1988 0.75
229 Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents. Xenobiotica 1987 0.75
230 Effect of imipramine on hepatic gamma-glutamyltransferase in female rats. Interaction with contraceptives. Biochem Pharmacol 1980 0.75
231 Study of the sequence tagged site (STS) in the beginning of human apo A4 gene region. Nucleic Acids Res 1990 0.75
232 Heparin specifically inhibits binding of apolipoprotein E to amyloid beta-peptide. Neurosci Lett 2000 0.75
233 Influence of oral contraceptives of differing dosages on alpha-1-antitrypsin, gamma-glutamyltransferase and alkaline phosphatase. Clin Chim Acta 1981 0.75
234 Cholesterol content of circulating immune complexes in patients with coronary stenosis and subjects without evidence of atherosclerosis. Clin Chem 1995 0.75
235 Weak relationships between blood antioxidant enzymes and serum lipids or apolipoproteins. J Intern Med 1991 0.75
236 Enzyme mediated superoxide radical formation initiated by exogenous molecules in rat brain preparations. Toxicol Appl Pharmacol 1991 0.75
237 Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis. J Invest Dermatol 1990 0.75
238 Effect of aflatoxin B1 on hepatic drug-metabolizing enzymes in female rats. Interaction with a contraceptive agent. Xenobiotica 1981 0.75
239 Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis. Clin Chem 1987 0.75
240 [Multiple molecular forms of serum gamma-glutamyltransferase: characterization and clinical significance]. Ann Biol Clin (Paris) 1984 0.75
241 'Threshold effect' of increasing tocopherol ingestion upon the microsomal epoxide hydrolase activity of rat liver. Food Addit Contam 1990 0.75
242 [From the concept of reference values to the creation of a bank of reference data]. Lab Delo 1979 0.75
243 [The place of gamma-glutamyltransferase among indirect tests of enzyme induction]. Bull Mem Acad R Med Belg 1984 0.75
244 Serum mitochondrial aspartate aminotransferase activity: not useful as a marker of excessive alcohol consumption in an unselected population. Clin Chem 1989 0.75
245 Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes. Genet Epidemiol 1994 0.75
246 [Tests of hepatic glycurono-conjugation done apropos of 2 cases of Crigler-Najjar disease]. Arch Fr Pediatr 1970 0.75
247 Effect of chronic ethanol administration on gamma-glutamyltransferase activities in plasma and in hepatic plasma membranes of male and female rats. Enzyme 1982 0.75
248 [Colorimetric determination of urinary urea with nioxime]. Clin Chim Acta 1967 0.75
249 [Prospective biology in prevention]. Arch Belg 1988 0.75
250 [Determination of reference values: a priori or a posteriori selection?]. Ann Biol Clin (Paris) 1986 0.75
251 gamma-Glutamyltransferase expression during all-trans retinoic acid-induced differentiation of hematopoietic cell lines. FEBS Lett 1995 0.75
252 Localization of a regulatory region on the 5'-untranslated region of human hepatoma HepG2 gamma-glutamyltransferase mRNA and response to dexamethasone and antisense oligonucleotide treatment. FEBS Lett 1994 0.75
253 [Absence of a relationship between the prevalence of markers for hepatitis B virus and the moderate consumption of alcohol]. Rev Epidemiol Sante Publique 1987 0.75
254 [Does mild exercise affect the reference values of the blood parameters? (author's transl)]. Clin Chim Acta 1974 0.75
255 High sensitivity of laser-induced fluorescence detection in capillary gel electrophoresis for accurate apolipoprotein E genotyping. Biotechniques 1997 0.75
256 Complexes of serum gamma-glutamyltransferase with apolipoproteins and immunoglobulin A. Clin Chem 1984 0.75
257 [Study of factors of biological variations acting on the concentration of the alpha-1-serous antitrypsin in a "common population" (author's transl)]. Ann Biol Clin (Paris) 1981 0.75
258 Commission on "Reference Values". Production of reference values in healthy subjects (document G, stage 3, version 1). Ann Biol Clin (Paris) 1981 0.75
259 [Ingestion of soybean epoxide oil. Effects on monooxygenases, epoxide hydrolase and activities of UDP glucuronosyltransferases in hepatic microsomes of the rat]. C R Seances Soc Biol Fil 1988 0.75
260 [Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study]. Arch Mal Coeur Vaiss 2001 0.75
261 [Human plasma lactic dehydrogenase activity: individual variations and reference intervals]. Ann Biol Clin (Paris) 1977 0.75
262 Stereospecific induction of rat liver bilirubin UDPglucuronosyltransferase and lauric acid 12-hydroxylation by the isomers of 2-phenylpropionic acid. Biochim Biophys Acta 1986 0.75
263 Single-step purification of two functional human apolipoprotein E variants hyperexpressed in Escherichia coli. Protein Expr Purif 1996 0.75
264 Avidin-biotin enzyme immunoassay of osteocalcin in serum or plasma. Clin Chem 1992 0.75
265 [APOC3, CETP, beta-fibrinogen and MTHFR are genetic determinants of carotid intim-media thickness (Stanislas cohort)]. Arch Mal Coeur Vaiss 2001 0.75
266 Direct determination of debrisoquine and 4-hydroxydebrisoquine using a high-performance liquid chromatographic switching technique. J Chromatogr 1987 0.75
267 [Solubilization by chlorpromazine of gamma glutamyltransferase of the plasma and microsomal membranes of rabbit liver (proceedings)]. Arch Int Physiol Biochim 1978 0.75
268 Letter: Guanidine interference in determination creatine kinase. Clin Chem 1975 0.75
269 [Systematic detection of hereditary metabolic encephalopathies]. Ann Pediatr (Paris) 1968 0.75
270 Induction of UDP-glucuronosyltransferase isozymes in male and female rat liver microsomes by an isoquinoleine derivative (52028 RP). Biochem Pharmacol 1989 0.75
271 Determination of flumequine and its 7-hydroxy metabolite by reversed-phase high-performance liquid chromatography. J Chromatogr 1987 0.75
272 A new enzyme immunoassay of microsomal rat liver epoxide hydrolase. Anal Biochem 1987 0.75
273 Effect of short- and long-term storage on human serum and recombinant apolipoprotein E concentration. Clin Chem Lab Med 2000 0.75
274 Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers. Clin Chim Acta 1997 0.75
275 Gene transfer technologies for the production of enzyme and protein reference materials. Clin Chim Acta 1997 0.75
276 The frequency of the factor V gene R506Q mutation varies between regions of France. Nouv Rev Fr Hematol 1995 0.75
277 [Effects of saccharo 1,4 lactone, EDTA and p-nitrophenol on the UDP-glucuronyl-transferase activity of rat liver microsomes]. C R Seances Soc Biol Fil 1973 0.75
278 Determination of frequency values of total LDH as a function of individual variation factors. Z Klin Chem Klin Biochem 1974 0.75
279 Repression of cytochrome P450 by cytokines: IL-1 beta counteracts clofibric acid induction of CYP4A in cultured fetal rat hepatocytes. Cell Biol Toxicol 1994 0.75
280 Glycosylation of gamma-glutamyltransferase is modified by ethanol in H5-6 hepatoma cell line. Clin Chim Acta 1994 0.75
281 Rapid method for simultaneous determination of phenobarbital, diphenylhydantoin and their main hydroxylated metabolites by nitrogen-selective gas chromatography. J Chromatogr 1980 0.75
282 An avidin-biotin ELISA for the measurement of mitochondrial aspartate aminotransferase in human serum. J Immunol Methods 1990 0.75
283 Development of an ELISA to study the polymorphism of dextromethorphan oxidation in a French population. Eur J Clin Pharmacol 1990 0.75
284 Effect of a dietary protein deficiency on the development of hepatic drug-metabolizing enzymes in young rats. Dev Pharmacol Ther 1982 0.75
285 Monometoxytrityl derivatives of uridine as inhibitors of a human recombinant UDP-glucuronosyltransferase: UGT1*6. Life Sci 1997 0.75
286 Interactions of perhexiline maleate and arylalkylamine derivatives with cytochrome P-450 and in-vitro hydroxylation. Biochem Pharmacol 1986 0.75
287 Differential action of thyroid hormones and chemically related compounds on the activity of UDP-glucuronosyltransferases and cytochrome P-450 isozymes in rat liver. Biochim Biophys Acta 1990 0.75
288 Alanine aminopeptidase in serum: biological variations and reference limits. Clin Chem 1988 0.75
289 Interlaboratory study of the IFCC method for alanine aminotransferase performed with use of a partly purified reference material. Clin Chem 1992 0.75
290 Length and sequence variation in the apolipoprotein B intron 20 Alu repeat. Genomics 1992 0.75
291 DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clin Genet 1994 0.75
292 Evaluation of a versatile reversed-phase high-performance liquid chromatographic system using cethexonium bromide as ion-pairing reagent for the analysis of glucuronic acid conjugates. J Chromatogr 1989 0.75
293 Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele? Ann Hum Genet 1996 0.75
294 Effect of apolipoprotein E on cell viability in a human neuroblastoma cell line: influence of oxidation and lipid-association. Neurosci Lett 2000 0.75
295 [Biological tests as indirect indicators of the activity of drug metabolizing enzymes. Use of glucaric acid and gamma-glutamyltransferase]. Ann Biol Clin (Paris) 1977 0.75
296 Effect of pretreatment with hydroxylated xenobiotics on the activities of rat liver UDP-glucuronosyl-transferases. Xenobiotica 1983 0.75
297 Plasma uric acid: mass spectrometric method for control and comparison of intra- and interlaboratory studies. Clin Chim Acta 1985 0.75
298 The relation of alcohol consumption to serum carotenoid and retinol levels. Effects of withdrawal. Int J Vitam Nutr Res 1994 0.75
299 [Reference values of lipoprotein(a) in a French population]. Presse Med 1994 0.75
300 Characterization of a new class of inhibitors of the recombinant human liver UDP-glucuronosyltransferase, UGT1*6. Biochim Biophys Acta 1995 0.75
301 Differential solubilization of rabbit liver plasma membrane gamma-glutamyltransferase by proteases and detergents: effect of phenobarbital treatment. Clin Chim Acta 1984 0.75
302 Changes of cerebral gamma glutamyltransferase activities after treatment with exogenous inducers. Neurochem Res 1987 0.75
303 [Evaluation of an immunological test for detecting occult fecal blood for case-finding in colorectal tumors]. Gastroenterol Clin Biol 1987 0.75
304 A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene. J Lipid Res 1992 0.75
305 Acetylation phenotypes and biological variation in a French Caucasian population. Eur J Clin Chem Clin Biochem 1993 0.75
306 Preparative high-performance liquid chromatographic method for the 2-hydroxy metabolite of carpipramine, excreted by isolated perfused liver. J Chromatogr 1989 0.75
307 Gamma-glutamyl transferase activity of liver plasma membranes in phenobarbital - treated rabbits. Pharmacol Res Commun 1981 0.75
308 The activity of 1-naphthol-UDP-glucuronosyltransferase in the brain. Neuropharmacology 1987 0.75
309 Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits. Clin Chem 1990 0.75
310 Heterogeneity of hepatic microsomal UDP-glucuronosyltransferase(s) activities: a new kinetic approach for the study of induction and specificity. J Pharm Sci 1994 0.75
311 Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes. Biochem Pharmacol 1989 0.75
312 Monoclonal antibodies to human kidney gamma-glutamyltransferase. Clin Chim Acta 1988 0.75
313 [Reference values in biology. Use and special value in preventive medicine]. Pathol Biol (Paris) 1975 0.75
314 Method for diphenylhydantoin and phenobarbital assay by gas chromatography. Pathol Biol (Paris) 1975 0.75
315 Distribution, metabolism, and elimination of phenobarbital in rats: physiologically based pharmacokinetic model. J Pharm Sci 1981 0.75
316 [Effects of Aldatense on laboratory tests. Comparison with a reference population]. Ann Biol Clin (Paris) 1984 0.75
317 Amino acid analysis by ion-exchange chromatography using a lithium elution gradient. Influence of methanol concentration and sample pH. J Chromatogr 1975 0.75
318 [Comparative effects of antiepileptics on the alkaline phosphatase and gamma glutamyltransferase activities in plasma and leukocytes]. C R Seances Soc Biol Fil 1978 0.75
319 UDP-glucuronosyltransferase activities in human liver microsomes and in some laboratory animal species. Biochem Pharmacol 1981 0.75
320 International Federation of Clinical Chemistry (IFCC) Scientific Committee: drug interferences and drug effects in clinical chemistry. Part 7. Data banks. J Clin Chem Clin Biochem 1987 0.75
321 [Biological constants in migrants]. Ann Biol Clin (Paris) 1988 0.75
322 Which, and how limited number of polymorphisms should be selected per disease, risk assessment, health profile or biological system? Clin Chem Lab Med 2003 0.75
323 APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 2001 0.75
324 [Biological variations and reference values of transferrin, immunoglobulin A and orosomucoid]. Ann Biol Clin (Paris) 1983 0.75
325 Provisional recommendation on the theory of reference values (1978). Part 1. The concept of reference values. Clin Chem 1979 0.75
326 Micro-scale two-dimensional electrophoresis of alkaline phosphatase from serum. Clin Chem 1988 0.75
327 [Drug conjugation in the brain]. Therapie 1995 0.75
328 Biochemical values of immigrant groups in north-east France. Ann Hum Biol 1990 0.75
329 Characterization of three human apolipoprotein E isoforms (E2, E3 and E4) expressed in Escherichia coli. Eur J Clin Chem Clin Biochem 1997 0.75
330 Enzyme immunoassay for flecainide. Clin Chim Acta 1990 0.75
331 [Present possibilities and future development of clinical proteomics]. Ann Biol Clin (Paris) 2007 0.75
332 Certification of an enzyme reference material for alkaline phosphatase (CRM 371). Clin Biochem 1991 0.75
333 [Revising the concept of reference values: a necessity]. Ann Biol Clin (Paris) 2001 0.75
334 [Effect of fructose 1-6 diphosphate on uncoupling and release of fructose 1-6 diphosphate aldolase from rat skeletal muscle]. C R Seances Soc Biol Fil 1973 0.75
335 The rat, a useful animal model for pharmacological studies on apolipoprotein E. Life Sci 1996 0.75
336 [Changes in blood cholesterol levels over a 10-year period; value of a single sample for predicting future blood cholesterol levels]. Arch Mal Coeur Vaiss 1995 0.75
337 [Place of gammaglutamyltransferase among the indirect procedures of evaluation of the function of enzymes of drug metabolism (author's transl)]. Ann Biol Clin (Paris) 1980 0.75
338 Stable expression of enzymatically active human pancreatic lipase in V79 cells: purification and characterization of the recombinant enzyme. Clin Chem 1994 0.75
339 Immobilization of microsomes into alginate beads is a convenient method for producing glucuronides from drugs. Appl Microbiol Biotechnol 1991 0.75
340 Kinetic constant determination of liver microsomal and purified UDP-glucuronosyltransferase after phenobarbital and 3-methylcholanthrene treatments in rats. Comp Biochem Physiol C 1986 0.75
341 [Influence of prolonged protein-free diet on the amino acid content of blood and muscles in rats]. Nutr Metab 1977 0.75
342 [Automation in enzymology. Critical and comparative study]. Pathol Biol (Paris) 1972 0.75
343 [Recent data on the metabolism of drugs by UDP-glucuronosyltransferases and sulfotransferases (author's transl)]. Ann Biol Clin (Paris) 1980 0.75
344 Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference. J Clin Chem Clin Biochem 1984 0.75
345 [Factors of variation and reference intervals for serum GST activity: the Stanislas cohort study]. Ann Biol Clin (Paris) 2004 0.75
346 Effects of RP 52028 and phenobarbital on mRNA levels of inducible and constitutive sex-specific cytochrome P450 isozymes in rat liver. Biochem Pharmacol 1991 0.75
347 Structural changes of liver microsomes in rat during neonatal life: influence on the glucuronidation rates of various substrates. Biochem Biophys Res Commun 1984 0.75
348 Multilocus approach to cardiovascular risk. Scand J Clin Lab Invest Suppl 1999 0.75
349 Production and certification of an enzyme reference material for gamma-glutamyltransferase (CRM 319). Part 2: Certification campaign. Clin Chem 1987 0.75
350 Drug effects in clinical chemistry. Part 1. The basic concepts. J Clin Chem Clin Biochem 1984 0.75
351 Kinetic properties of rat liver UDPglucuronosyltransferase during ontogenesis. Biochem Soc Trans 1984 0.75
352 International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 4. Clinical laboratory tests on laboratory animals during toxicity studies. J Clin Chem Clin Biochem 1988 0.75
353 Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol. J Toxicol Environ Health 1996 0.75
354 [Drugs and reference values in biology. I. Oral contraceptives]. Ann Biol Clin (Paris) 1974 0.75
355 Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite. Eur J Drug Metab Pharmacokinet 1981 0.75
356 Pharmacogenetics: from bench to bedside. Clin Chem Lab Med 2003 0.75
357 Which are the best tools for specific clinical application (chips, multiplex, mass spec profile, etc.)? Clin Chem Lab Med 2003 0.75
358 Dextromethorphan O-demethylation in a large number of French Caucasian families. Pharmacogenetics 1992 0.75
359 [Reference values of chemical constituents and plasma enzymes in minipigs]. Ann Biol Clin (Paris) 1987 0.75
360 Characterization and regulatory effect of gamma-glutamyltransferase messenger RNA untranslated regions in human leukemia. Leukemia 1995 0.75
361 Developmental- and tissue-specific DNA methylation patterns and expression of rat gamma-glutamyltransferase. Biochem Mol Biol Int 1995 0.75
362 Competitive inhibition of glucuronidation by p-hydroxyphenyl hydantoin. Biochem Pharmacol 1975 0.75
363 Perturbation of laboratory test results by analytical interferences and drug effects. Talanta 1984 0.75
364 Variations of plasmatic enzymes during exercise. Enzyme 1974 0.75
365 Biological variations in laboratory tests (document D, stage 3). Ann Biol Clin (Paris) 1979 0.75
366 [Color reactions and fluorescence of biologic urea derivatives with alpha-diketones]. Bull Soc Chim Biol (Paris) 1967 0.75
367 [Representation of SFBC]. Ann Biol Clin (Paris) 2000 0.75
368 Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population. Clin Chem 1991 0.75
369 [Effects of the ingestion of oxidized fish oils on hepatic microsomal enzyme activities and membrane fluidity in rats. Influence of tocopherol overload]. C R Seances Soc Biol Fil 1987 0.75
370 Induction of group-1 and group-2 UDP-glucuronosyltransferase in microsomes from the livers of C57 Bl/6 mice. Toxicol Lett 1981 0.75
371 Production, cross reactivity, and epitope analysis of monoclonal antibodies against rat kidney gamma glutamyltransferase. Cell Biol Toxicol 1990 0.75
372 Effect of drugs on laboratory tests. Guidelines for evaluation of analytical interference (document B, stage 3, version 1). Ann Biol Clin (Paris) 1984 0.75
373 Induced hepatotoxicity in female rats by aflatoxin B1 and ethynylestradiol interaction. Toxicol Appl Pharmacol 1983 0.75
374 [Study of the urea-diacetylmonoxime reaction. II. Effects of various adjuvants. Choice of a method of estimation]. Ann Biol Clin (Paris) 1968 0.75
375 Société Française de Biologie Clinique. Section of physiopathology. Commission "reference values". Utilisation of reference values. (Document J, stage 3, version 1). Ann Biol Clin (Paris) 1982 0.75
376 [Automatic analysis of creatine-phospho-kinase. Application to the chromatography of tissue isoenzymes]. Ann Biol Clin (Paris) 1970 0.75
377 [Criteria for addition of apolipoprotein B measurement during routine health screening examinations: validation in a Stanislas cohort. The Biologist's Group of the Health Examination Center]. Ann Biol Clin (Paris) 1998 0.75
378 Quantitative measurement of cerebral cytochrome P-450 by second derivative spectrophotometry. J Neurosci Methods 1987 0.75
379 Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes. Int J Clin Pharmacol Res 1983 0.75
380 N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells. Drug Metab Dispos 1994 0.75
381 Immobilization of pig liver microsomes. Stability of cytochrome P-450-dependent monooxygenase activities. Appl Biochem Biotechnol 1986 0.75
382 Conformational studies of NADPH cytochrome P-450 reductase by circular dichroism: interaction with phospholipids. Int J Biochem 1985 0.75
383 Selection of people for the production of population reference values [proceedings]. Ann Biol Clin (Paris) 1978 0.75
384 Influence of glucose and inhibitors of glycolysis on release of total proteins and enzymes from human leukocytes. Clin Chim Acta 1977 0.75
385 [Comparison of values, obtained on heparinised serum or plasma, for common biochemical examinations]. Ann Biol Clin (Paris) 1976 0.75
386 Comparison of procedures for extracting free amino acids from polymorphonuclear lekocytes. Clin Chem 1976 0.75
387 Laboratory tests in monitoring drug administration (Document F, Stage 3, Version 1). Ann Biol Clin (Paris) 1988 0.75
388 Conformational study of purified epoxide hydrolase from rat liver. Chem Biol Interact 1982 0.75
389 Expression of the human UDP-glucuronosyltransferase UGT1*6 in Escherichia coli. Influence of bacterial signal peptides on the production and localization of the recombinant protein. FEBS Lett 1994 0.75
390 UDP-glucuronosyltransferase(s) activities towards natural substrates in rat liver microsomes. Kinetic properties and influence of triton X-100 activation. Pharmacol Res Commun 1985 0.75
391 Molecular pharmacophore determination of lipid lowering drugs with the receptor mapping method. Mini Rev Med Chem 2002 0.75
392 Reference materials for clinical enzymology: the work of the Community Bureau of Reference of the European Community. Ann Clin Biochem 1986 0.75
393 Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat. Biochem Pharmacol 1987 0.75
394 Determination of UDP-glucuronyltransferase using UDP-(14-C)glucuronic acid. Biochem Pharmacol 1975 0.75
395 International Federation of Clinical Chemistry (IFCC) Scientific Committee: drug interferences and drug effects in clinical chemistry. Part 5. Laboratory tests during clinical trials. J Clin Chem Clin Biochem 1987 0.75
396 Personal and familial factors in cholesterolemia: criteria for selection of a reference population. Clin Chem 1980 0.75
397 Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats. Gen Pharmacol 1991 0.75
398 Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes. Drug Metab Dispos 1993 0.75
399 Ornithine carbamoyl transferase activity. Use of a bovine liver extract in quality control. Clin Chim Acta 1976 0.75
400 A method for the determination of UDP-glucuronosyltransferase activity toward arylcarboxylic acids. Anal Biochem 1993 0.75
401 [Influence of oral contraceptive agents on the concentration of amino acids in leukocytes of supposedly healthy women (author's transl)]. Clin Chim Acta 1977 0.75
402 Continuous in vivo measurement of creatine kinase variations in man during an exercise. Clin Chim Acta 1976 0.75
403 NADPH:cytochrome P-450(c) reductase: biochemical characterization in rat brain and cultured neurons and evolution of activity during development. Neurochem Res 1989 0.75
404 Establishment of a V79 transfected cell line highly producing recombinant human gamma-glutamyltransferase. Toxicology 1993 0.75
405 Identification of novel phencyclidine metabolites formed in vitro by rabbit microsomal metabolism. Xenobiotica 1991 0.75
406 Reference materials and reference measurement systems in laboratory medicine--a major international meeting organized by the International Federation of Clinical Chemistry (IFCC), Geneva, October 5-7, 1994. Eur J Clin Chem Clin Biochem 1995 0.75
407 Capillary electrophoretic analysis of recombinant human apolipoprotein E. Calibration mode of a protein reference material. J Chromatogr A 1999 0.75
408 Commission on "effects of drugs on laboratory tests". Introductory considerations on drug effects in clinical biochemistry (document A, stage 3, January 1981). Ann Biol Clin (Paris) 1981 0.75
409 5-Azacytidine modulates gamma-glutamyltransferase and glutathione levels in two human prostatic adenocarcinoma cell lines. Biochem Mol Biol Int 1998 0.75
410 Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inducible enzymes in patients with cholestasis. Eur J Clin Pharmacol 1987 0.75
411 [A prospective study on the prevalence of metabolic syndrome among healthy French families: the importance of plasma concentration of TNF-alpha in addition to its genetic polymorphism]. Ann Pharm Fr 2007 0.75
412 Stereospecificity of enzyme induction by 2-phenylpropionic acid. Pharmacol Ther 1987 0.75
413 [Inhibition of cytochromes P-450. Biochemical mechanisms and possible therapeutic consequences. I--Inactivation by formation of reversible complexes]. J Toxicol Clin Exp 1991 0.75
414 [Comparative study of the reactivity of guanidine with alpha-diketones]. Clin Chim Acta 1970 0.75
415 [Reference materials in clinical enzymology]. Ann Biol Clin (Paris) 1986 0.75
416 Evaluation of biological effects of drugs (Document C, Stage 3, Version 1). Ann Biol Clin (Paris) 1988 0.75
417 Colorimetric measurement of ornithine carbamoyl transferase activity in plasma, and results for a supposedly healthy population. Clin Chem 1975 0.75
418 [Alzheimer disease: hypotheses implicating apolipoproteins E]. Presse Med 1996 0.75
419 Drug regulation of gamma-glutamyltransferase, a plasma membrane glycoprotein. Prog Clin Biol Res 1982 0.75
420 Inhibition studies of microsomal UDP-glucuronosyltransferase activities by furosemide and salicylamide. Pharmacol Res Commun 1984 0.75
421 Effects of membrane perturbants on UDP-glucuronosyltransferase activity in rat-liver microsomes. Circular dichroism studies. Chem Biol Interact 1979 0.75
422 Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives. Biochem Biophys Res Commun 1992 0.75
423 [Enzyme and protein release from human granulocytes: effect of ATP]. C R Seances Soc Biol Fil 1975 0.75
424 Variations in human biological parameters as a function of sampling time. Z Klin Chem Klin Biochem 1974 0.75
425 Pressure effects on the apparent viscosity of artificial dipalmitoylphosphatidylcholine and dimyristoylphosphatidylcholine membranes using intramolecular excimer probe. Biochim Biophys Acta 1983 0.75
426 [Study of the coloring reaction urea-diacetylmonoxime I. Influence of acids]. Ann Biol Clin (Paris) 1968 0.75
427 [Evaluation of the Coulter Counter S+IV LMG: estimation of the leukocyte formula. Comparison with microscopic methods]. Ann Biol Clin (Paris) 1986 0.75
428 Protein and enzyme release from human leukocytes: influence of phenothiazine derivatives. Chem Biol Interact 1977 0.75
429 Peroxisome proliferators as inducers and substrates of UDP-glucuronosyltransferases. Biol Cell 1993 0.75
430 [Protein release from human leucocytes. Influence of medium and time of incubation (author's transl)]. Clin Chim Acta 1974 0.75
431 [UDP-glucuronosyltransferases and glucuronoconjugation]. Therapie 1985 0.75
432 [Effect of thyroid status on microsomal enzymes during liver regeneration in the rat]. C R Seances Soc Biol Fil 1985 0.75